Latest Neuroscientific Biopharmaceuticals (ASX:NSB) News
Page 2
Page 2 of 3
NeuroScientific Advances StemSmart Clinical Program and Manufacturing Scale-Up
30 Apr 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
NeuroScientific Biopharmaceuticals Advances Clinical Programs Amid $1.7M Half-Year Loss
25 Feb 2026
NeuroScientific Reports Early Success in StemSmart™ Crohn’s Treatment Program
30 Jan 2026
Market Wrap - Week 3 (12 Jan -> 16 Jan) 2026
18 Jan 2026
NeuroScientific’s StemSmart™ Shows Promise in Tough Crohn’s Cases
13 Jan 2026
NeuroScientific Advances StemSmart™ Therapy with Fourth Patient Treatment
11 Nov 2025
NeuroScientific Advances StemSmart™ Trials with New Leadership and Manufacturing Scale-Up
30 Oct 2025
NeuroScientific Posts $1.85M Loss Amid StemSmart™ Acquisition and Clinical Push
28 Aug 2025
StemSmart™ MSC Therapy Revives Hope in Renal Transplant Patients
27 Aug 2025
NeuroScientific Taps Nathan Smith to Drive StemSmart Cell Therapy Forward
28 July 2025
NeuroScientific Advances StemSmart Tech with Crohn’s Trial and $3.5M Raise
23 July 2025